ELAB - Company ID 0001840563
The table below shows Elevai Labs Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | $650.60K | $733.40K | $804.07K | $624.84K | $557.38K | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $932.51K | $253.56K | $128.47K | - | - | $986.42K |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $20.83M |
| $16.39M |
| $9.77M |
| $7.30M |
| $6.82M |
| $8.23M |
| Property, plant & equipment | $1.90M | $1.75M | $413.45K | $1.09K | $1.09K | $52.53K |
| Goodwill | $3.04M | $1.86M | $959.53K | - | - | - |
| Total assets | $36.56M | $26.03M | $14.94M | $9.38M | $8.89M | $11.21M |
| Accounts payable | - | - | - | - | - | $1.08M |
| Total current liabilities | $15.33M | $11.30M | $5.46M | $326.30K | $760.27K | $2.13M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $19.83M | $13.43M | $6.45M | $326.30K | $760.27K | $2.65M |
| Retained earnings | -$28.93M | -$25.98M | -$18.03M | -$15.44M | -$14.88M | -$11.33M |
| Total equity | $16.74M | $12.61M | $8.49M | $9.05M | $8.13M | $8.56M |